Workflow
Allurion Technologies(ALUR)
icon
Search documents
Allurion's Virtual Care Suite Digital Platform Accelerates Commercial Expansion With New Strategic Partnerships
Businesswire· 2024-01-17 13:00
NATICK, Mass.--(BUSINESS WIRE)--Allurion Technologies, Inc. (NYSE:ALUR), a company dedicated to ending obesity, today announced further expansion of its Virtual Care Suite (VCS) digital platform with new commercial agreements signed with Lazeo, France's largest aesthetic and weight loss clinic chain, and Transform, UK's largest aesthetic and weight loss clinic chain. After recently expanding its commercial agreement with Weight Doctors®—Germany’s leading group of private clinics and centers for weight loss ...
Allurion Technologies(ALUR) - 2023 Q3 - Earnings Call Transcript
2023-11-17 17:07
Allurion Technologies Inc. (NYSE:ALUR) Q3 2023 Results Conference Call November 13, 2023 8:30 AM ET Company Participants Mike Cavanaugh - ICR of Westwicke Shantanu Gaur - Founder and Chief Executive Officer Chris Geberth - Chief Financial Officer Conference Call Participants Anthony Petrone - Mizuho Ross Osborn - Cantor Fitzgerald Ryan Zimmerman - BTIG Chris Pasquale - Nephron Research Operator Hello, and welcome to the Allurion Third Quarter Earnings Call. All lines have been placed on mute to prevent any ...
Allurion Technologies(ALUR) - 2023 Q3 - Quarterly Report
2023-11-13 16:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _________________ to _________________ Commission File Number: 001-41767 Allurion Technologies, Inc. (Exact Name of Registrant as Specified in its Charter) ...
Allurion Technologies(ALUR) - 2023 Q3 - Quarterly Results
2023-11-12 16:00
Exhibit 99.1 Allurion Reports Third Quarter 2023 Financial Results and Provides Business Update Completed NYSE listing and business combination generating $92M in net proceeds Generated 40% sequential revenue growth in first quarter as a public company Completed enrollment in AUDACITY FDA pivotal trial for Allurion Balloon Launched Coach Iris, a conversational, 24/7, and generative AI-powered weight loss coach Natick, MA – November 13, 2023 – Allurion Technologies, Inc. (NYSE: ALUR) ("Allurion"), a company ...
Allurion Technologies(ALUR) - 2023 Q2 - Quarterly Report
2023-10-19 16:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 Title of each classTrading Symbol(s) Name of each exchange on which registered Common Stock, par value $0.0001 per share ALUR The New York Stock Exchange Warrants, each exercisable for 1.420455 shares of Common Stock for $8.10 per share ALUR WS The New York Stock Exchange FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 OR ☐ TRANSITI ...